The phase 3 PREDICT-1 trial is evaluating licaminlimab in patients with dry eye disease, with a primary analysis focused on a genetically defined subgroup.
Optometric Management caught up with Cory Lappin, OD, who recently joined our board, at the American Academy of Optometry Annual Meeting in Anaheim. Dr. Lappin discussed his sessions in dry eye and ocular surface disease from the week.
Celebrating 40 years. Eyecare Business reached out to our board members and past #EBGameChangers for their thoughts on how eyewear and eye care have changed since our launch in 1986.
Celebrating 40 years. Eyecare Business reached out to our board members and past #EBGameChangers for their thoughts on how eyewear and eye care have changed since our launch in 1986.